People · Operator
Named in public records as an officer, director or promoter · active 2020–2024 · Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RedShift BioAnalytics, Inc. | — | Other Technology | Series B | $60.5M | $31.7M | 2020 |
| PAK BioSolutions, Inc. | — | Other Technology | Series A | $5.0M | $28.1M | 2024 |
Charles Purtell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Purtell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Frank Smith | 1 | 4 |
| Bryson Hollimon | 1 | 4 |
| William Cadogan | 1 | 3 |
| Don Bossi | 1 | 2 |
| Paul Tardif | 1 | 2 |
| Amol Chaubal | 1 | 2 |
| Mark Cafazzo | 1 | 1 |
| Julien Bradley | 1 | 1 |
| Rob Carson | 1 | 1 |
| Bryson Holliman | 1 | 1 |
| Joanna Pezzini | 1 | 1 |
| Daniel Kidle | 1 | 1 |
| Kevin Hill-Byrne | 1 | 1 |
| Charles Marshall | 1 | 1 |
| Eugene Ma | 1 | 1 |
| Susan Holleran | 1 | 1 |
| Wouter Meuleman | 1 | 1 |
| Thomas O'Lenic | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.